Skip to main content

2020 R&D Spending and Intensity Benchmarks

By: PRLog
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

VIRGINIA BEACH, Va. - June 1, 2021 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, now in its 45th annual edition, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2020 with budgets of drug companies increasing by over 12% to over $140 billion. Software companies continued to contribute a total of over $73 billion to this investment pool.

The biggest single R&D investor in 2020 was Alphabet at over $25 billion, followed by Microsoft at $22 billion, and then Apple and Facebook at $18 billion. Firms involved with digital content are investing much more heavily than those in more traditional arenas.

Pharmaceutical firms continued significant R&D spending in 2020. Merck, the top spender at $13.5 billion, is followed by Johnson & Johnson, Bristol Myers Squibb, Pfizer and Novartis, each spending over $8 billion. The biotech industry, led by Gilead Sciences, grew R&D by over 33% to over $31 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3 billion, an increase of over two percent.

R&D budgets of semiconductor makers grew to over $51 billion, an increase of 8.3%. Intel had the largest R&D budget, $13.5 billion, an 8% increase over 2019. R&D budgets of the industries that are major suppliers to the infrastructure of the Internet cloud also have increased R&D spending.

2020 R&D spending of the automotive industry, led by Toyota, Honda and Ford each spending over $7 billion, was essentially flat from the 2019 total with industry revenues down 8.2% .

About the Study

R&D Ratios & Budgets contains fiscal 2019 and 2020 R&D spending, 2020 revenue and 2020 R&D intensity ratio, as well as 2019 and 2020 annual growth rates in R&D spending and sales for over 2,500 firms. Over 290 industry summaries of the same information are provided. The study reports for each company a low and high value for the R&D-to-sales ratio (also known as R&D intensity) for the last five years to indicate stability of R&D spending.

R&D Ratios & Budgets is used for budget planning, monitoring competition, identifying joint venture partners, and spotting acquisition candidates.

The 2021 edition of the PDF report is $ 395 and the report along with Excel datafiles is $ 495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information: 800-205-0030 or visit the company's web site for immediate download at www.saiBooks.com under Area of Expertise: Research & Development Spending.

Contact
Carol J Greenhut
***@saibooks.com

Photos: (Click photo to enlarge)

Schonfeld & Associates, Inc. Logo R&D Intensity by Sector Sample Page from R&D Ratios & Budgets Growth in R&D Spending By Country of Headquarters

Read Full Story - 2020 R&D Spending and Intensity Benchmarks | More news from this source

Press release distribution by PRLog

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.25
+0.75 (0.30%)
AAPL  264.01
-2.42 (-0.91%)
AMD  272.95
+14.83 (5.75%)
BAC  53.74
-0.58 (-1.06%)
GOOG  332.41
-2.06 (-0.62%)
META  674.48
+2.90 (0.43%)
MSFT  419.35
+8.13 (1.98%)
NVDA  198.09
-0.78 (-0.39%)
ORCL  177.81
+8.00 (4.71%)
TSLA  387.57
-4.38 (-1.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.